WorldCat Identities

Carlson, Kristina 1949-

Works: 14 works in 54 publications in 5 languages and 201 library holdings
Genres: Handbooks and manuals  Fiction 
Roles: Author
Publication Timeline
Most widely held works by Kristina Carlson
Mr Darwin's gardener by Kristina Carlson( Book )

18 editions published between 2009 and 2013 in 3 languages and held by 116 WorldCat member libraries worldwide

"A postmodern Victorian novel about faith, knowledge and our inner needs. The late 1870s, the Kentish village of Downe. The villagers gather in church one rainy Sunday. Only Thomas Davies stays away. The eccentric loner, father of two and a grief-stricken widower, works as a gardener for the notorious naturalist, Charles Darwin. He shuns religion. But now Thomas needs answers. What should he believe in? And why should he continue to live?"--Back cover
Maan ääreen by Kristina Carlson( Book )

12 editions published between 1999 and 2014 in 3 languages and held by 42 WorldCat member libraries worldwide

William N. päiväkirja by Kristina Carlson( Book )

8 editions published between 2011 and 2012 in Finnish and held by 15 WorldCat member libraries worldwide

Indstillet til Finlandiaprisen (2011)
Hämärän valo : runoja by Kristina Carlson( Book )

5 editions published between 1986 and 2002 in Finnish and held by 12 WorldCat member libraries worldwide

Autologous bone marrow transplantation by Kristina Carlson( Book )

1 edition published in 1994 in English and held by 5 WorldCat member libraries worldwide

Autologous bone marrow transplantation : studies with special reference to cardiac, pulmonary, renal, thyroid and skeletal effects by Kristina Carlson( Book )

2 editions published in 1994 in English and held by 2 WorldCat member libraries worldwide

Essential principles for fundraising success : an answer manual for the everyday challenges of raising money by G. Douglass Alexander( Book )

1 edition published in 2005 in English and held by 2 WorldCat member libraries worldwide

Based on the enduring principles of fundraising, this important resource shows how to master the three mainstays of fundraising - developing a case statement, creating a campaign strategy, and securing big gifts. Essential Principles for Fundraising Success also offers creative, out-of-the-box solutions for convincing reluctant board members and other stakeholders to follow proven, effective fundraising strategies."
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011 by Krista Vaht( )

1 edition published in 2017 in English and held by 1 WorldCat member library worldwide

A plastic anemia is a rare life-threatening disease. However, since the introduction of immunosuppressive therapy and allogeneic stem cell transplantation, the outcome has improved considerably, and the 5-year survival is reported to be 70-80% in selected patient cohorts. Yet, contemporary population-based data on incidence and survival are lacking. We performed a national retrospective study to determine the incidence, treatment, and survival of patients with aplastic anemia diagnosed in Sweden from 2000-2011. Patients were included via the National Patient Registry, and diagnosed according to the Camitta criteria. In total, 257 confirmed cases were identified, with an overall incidence of 2.35 (95% CI: 2.06-2.64) cases per million inhabitants per year. Median age was 60 years (range: 2-92), and median follow up was 76 (0-193) months. Primary treatments included immunosuppressive therapy (63%), allogenic stem cell transplantation (10%), or single-agent cyclosporine/no specific therapy (27%). The 5-year survival was 90.7% in patients aged 0-18 years, 90.5% in patients aged 19-39 years, 70.7% in patients aged 40-59 years, and 38.1% in patients aged amp;gt;= 60 years. Multivariate analysis showed that age (both 40-59 and amp;gt;= 60 age groups), very severe aplastic anemia and single-agent cyclosporine/no specific therapy were independent risk factors for inferior survival. In conclusion, younger aplastic anemia patients experience a very good long-term survival, while that of patients amp;gt;= 60 years in particular remains poor. Apparently, the challenge today is to improve the management of older aplastic anemia patients, and prospective studies to address this medical need are warranted
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register( )

1 edition published in 2017 in English and held by 1 WorldCat member library worldwide

Abstract: Solitary plasmacytoma (SP) and plasma cell leukemia (PCL) are uncommon (3-6%) types of plasma cell disease. The risk of progression to symptomatic multiple myeloma (MM) is probably important for the outcome of SP. PCL is rare and has a dismal outcome. In this study, we report on incidence and survival in PCL/SP, and progression to MM in SP, using the prospective observational Swedish Multiple Myeloma Register designed to document all newly diagnosed plasma cell diseases in Sweden since 2008. Both solitary bone plasmacytoma (SBP) (n =124) and extramedullary plasmacytoma (EMP) (n =67) have better overall survival (OS) than MM (n =3549). Progression to MM was higher in SBP than in EMP (35% and 7% at 2 years, respectively), but this did not translate into better survival in EMP. In spite of treatment developments, the OS of primary PCL is still dismal (median of 11 months, 0% at 5 years). Hence, there is a great need for diagnostic and treatment guidelines as well as prospective studies addressing the role for alternative treatment options, such as allogeneic stem cell transplantation and monoclonal antibodies in the treatment of PCL
Härra Darwini aednik by Kristina Carlson( Book )

1 edition published in 2012 in Estonian and held by 1 WorldCat member library worldwide

Maan ääreen by Kristina Carlson( Recording )

1 edition published in 1999 in Finnish and held by 1 WorldCat member library worldwide

Murha Bulevardilla : 10 rikoskertomusta( Book )

1 edition published in 1994 in Finnish and held by 1 WorldCat member library worldwide

Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry by Cecilie Hveding Blimark( )

1 edition published in 2018 in English and held by 1 WorldCat member library worldwide

Epidemiology and outcome of myeloma are mainly reported from large university centers and collaborative groups, and do not represent real-world patients. The Swedish Myeloma Registry is a prospective population-based registry documenting characteristics, treatment and outcome in newly diagnosed myeloma, including asymptomatic and localized forms, with the purpose of improving disease management and outcome. This report presents information on patients diagnosed between 2008 and 2015, including data on first-line treatment in patients diagnosed up to 2014, with a follow up until December 2016. We present age-adjusted incidence, patients characteristics at baseline, treatment, response, and survival. Baseline data were available with a 97% coverage in 4904 patients (median age 71 years, males 70 years, females 73 years; 72% were 65 years or older), and at 1-year follow up in 3558 patients with symptomatic disease (92% of patients initially reported). The age-adjusted incidence was 6.8 myeloma cases per 100,000 inhabi-ants per year. Among initially symptomatic patients (n= 3988), 77% had osteolytic lesions or compression fractures, 49% had anemia, 18% impaired kidney function, and 13% hypercalcemia. High-dose therapy with autologous stem cell transplantation was given to 77% of patients aged up to 66 years, and to 22% of patients aged 66-70 years. In the study period, 68% received bortezomib, thalidomide, and/or lenalidomide as part of the first-line treatment, rising from 31% in 2008 to 81% in 2014. In active myeloma, the median relative survival of patients aged 65 years or under was 7.7 years, and 3.4 years in patients aged 66 years and over. Patients diagnosed with myeloma in more recent years were associated with significantly higher rates of complete or very good partial remission (Pamp;lt;0.05), and with a significantly higher survival, with a Hazard Ratio (HR) of 0.84 (95% CI: 0.77-0.92; Pamp;lt;0.05). There was a small, but significant survival benefit in patients treated at university hospitals (HR 0.93; 95% CI: 0.87-0.99; Pamp;lt;0.05). We report here on a near complete real-world population of myeloma patients during an 8-year period; a period in which newer drugs were implemented into standard practice. The overall incidence and median age were both higher than in most previous studies, indicating a more complete coverage of older patients. Myeloma survival in Sweden is comparable to other large registry studies, and responses and survival improved during the study period
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party( )

1 edition published in 2015 in English and held by 1 WorldCat member library worldwide

Background: Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the central nervous system, hallmarked by pathogenic anti-aquaporin 4 antibodies. NMO prognosis is worse compared with multiple sclerosis. Objective: The European Group for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP) conducted a retrospective survey to analyze disease outcome following autologous stem cell transplantation (ASCT). Methods: This retrospective multicenter study assessed the efficacy and safety of ASCT in 16 patients suffering from refractory NMO reported to the EBMT registry between 2001 and 2011. Results: Fifteen patients were successfully mobilized with cyclophosphamide (Cy) and G-CSF, one with G-CSF alone. All patients received an unmanipulated autologous peripheral blood stem cell graft, after conditioning with BEAM plus anti-thymocyte globulin (ATG, n = 9 patients), thiotepa-Cy ( n = 3) or Cy (200 mg/kg) plus ATG ( n = 4). After a median follow-up of 47 months, three of 16 cases were progression and treatment free, while in the remaining 13 patients further treatments were administered for disability progression or relapse after ASCT. Altogether, relapse-free survival at three and five years was 31% and 10%, respectively, while progression-free survival remained 48% at three and five years. Conclusions: In these NMO patients, highly resistant to conventional treatment, ASCT allows for temporary control of the disease, despite a tendency to progress or relapse in the long term
moreShow More Titles
fewerShow Fewer Titles
Audience Level
Audience Level
  Kids General Special  
Audience level: 0.78 (from 0.31 for Essential ... to 0.99 for Maan äär ...)

Essential principles for fundraising success : an answer manual for the everyday challenges of raising money
Alternative Names

controlled identityLampinen, Mari, 1949-

Alapuro, Kristina 1949-

Carlson, Anna Kristina 1949-

Kristina Carlson finnische Schriftstellerin

Kristina Carlson Finnish journalist and writer

Kristina Carlson Fins journaliste

Kristina Carlson finská spisovatelka a básnířka

Kristina Carlson suomalainen kirjailija

Finnish (33)

English (15)

German (3)

Czech (2)

Estonian (1)